A 34-year-old woman was diagnosed with type 1 diabetes mellitus and treated with insulin for 24 years. The patient has a family history of diabetes in three consecutive generations. Her Whole exon sequencing showed a heterozygous mutation in the ABCC8 gene, and it also found some of her relatives to carry this mutation. She was diagnosed with MODY12 and received glimepiride therapy with the achievement of good glycaemic control.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11091440 | PMC |
| http://dx.doi.org/10.1016/j.clinme.2024.100033 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Precision therapy for Developmental delay, Epilepsy and Neonatal Diabetes syndrome in the era of genomics.
Med J Armed Forces India
December 2024
Director & Commandant, Armed Forces Medical College, Pune, India.
Neonatal diabetes mellitus is a rare disorder with prevalence of one in 400,000 live births that's defined by persistent hyperglycaemia within the first six months of life. Neonatal diabetes is heterogeneous and can be transient or permanent. Developmental delay, Epilepsy and Neonatal Diabetes (DEND) syndrome is characterised by developmental delay, epilepsy, and neonatal diabetes.
View Article and Find Full Text PDFMild Congenital Hyperinsulinism Caused by Mutation in Human Gene.
JCEM Case Rep
December 2024
Endocrinology Research Centre, Moscow, 117036, Russian Federation.
Congenital hyperinsulinism (CHI) is a rare hereditary disease characterized by the development of hypoglycemia in both infants and adult patients. CHI may be induced by activating mutations in the () gene, which encodes the human glucokinase enzyme. This form of the disease is characterized by considerable phenotypic heterogeneity and may vary in severity of its course.
View Article and Find Full Text PDFArticle Synopsis
- A four-year-old girl experienced persistent hypoglycemia shortly after birth and was diagnosed with congenital hyperinsulinism due to genetic mutations in the ABCC8 gene.
- She did not respond to typical treatments like oral diazoxide but showed improvement with subcutaneous somatostatin injections.
- At age three and a half, her treatment was changed to a long-acting somatostatin analogue, leading to better blood sugar control, normal growth, and the ability to stop tube feeding.
Genetic Variations in Hyperinsulinemic Hypoglycemia: Active versus Inactive Mutations.
Diabetes Metab Syndr Obes
November 2024
Department of Pharmaceutical Technology, Jordan University of Science and Technology, Irbid, Jordan.
Article Synopsis
- Hyperinsulinemic Hypoglycemia (HH) is a rare condition in newborns characterized by low blood glucose levels, posing serious risks particularly to brain health without proper treatment.
- It can be caused by mutations in 16 genes related to glucose metabolism and insulin release, which can affect pancreatic beta cells either diffusely or locally.
- The review focuses on genetic variations, diagnosis, and treatment options for Hyperinsulinemic Hypoglycemia.
The p.(Gly111Arg) ABCC8 Variant: A Founder Mutation Causing Congenital Hyperinsulinism in the Indian Agarwal Community.
Clin Genet
November 2024
Department of Clinical and Biomedical Science, University of Exeter, Exeter, UK.
Loss-of-function ABCC8 variants are the commonest cause of congenital hyperinsulinism. On a systematic search of our databases, the p.(Gly111Arg) ABCC8 variant was identified in 26 individuals, of which 23 were from the Indian Agarwal community.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!